LAMICTAL XR 25 mg/1 (Lamotrigine TABLET, FILM COATED, EXTENDED RELEASE) 25 mg/1

LAMICTAL XR 25 mg is an extended-release tablet containing lamotrigine, used for managing certain types of seizures and mood disorders. This medication is designed for oral administration and is manufactured by GlaxoSmithKline LLC.

Strength

25 mg/1

Pack Size

30 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (0173-0754-00)

Manufacturer / TM Owner

GlaxoSmithKline LLC

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

LAMICTAL XR 25 mg is primarily used as an anticonvulsant to help control seizures in adults and children. It may also be prescribed for the maintenance treatment of bipolar disorder to delay mood episodes. Lamotrigine works by stabilizing electrical activity in the brain, which can help prevent seizures and mood swings. Always consult a healthcare provider to determine if this medication is suitable for your condition.

Side Effects

Common effects of LAMICTAL XR 25 mg may include dizziness, headache, nausea, and blurred vision. Some users might experience skin rashes, which can be serious and require immediate medical attention. It's important to monitor for any unusual symptoms and report them to a healthcare professional.

Precautions & Warnings

LAMICTAL XR 25 mg should be handled with care, especially regarding dosage adjustments and potential side effects. It is crucial to follow the prescribed dosage and not to stop taking the medication abruptly without consulting a healthcare provider. Pregnant women or those planning to become pregnant should discuss the risks and benefits with their doctor.

Avoid Interactions

LAMICTAL XR 25 mg may interact with other medications, including birth control pills, anticonvulsants, and certain antidepressants. Alcohol consumption should be avoided as it can increase the risk of side effects. Always inform your healthcare provider about all medications you are taking to avoid potential interactions.

Frequently Asked Questions

LAMICTAL XR 25 mg is used to manage certain types of seizures and to help prevent mood episodes in bipolar disorder.

LAMICTAL XR 25 mg should be taken orally, exactly as prescribed by your healthcare provider. Do not crush or chew the extended-release tablets.

Common side effects may include dizziness, headache, nausea, and blurred vision. Serious skin rashes are also possible and require immediate medical attention.

LAMICTAL XR 25 mg may interact with other medications, so it's important to inform your healthcare provider about all medications you are taking.

Pregnant women or those planning to become pregnant should discuss the risks and benefits of LAMICTAL XR 25 mg with their healthcare provider.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.